People: Camurus AB (CAMX.ST)
Mr. Per Olof Wallstrom has been Independent Chairman of the Board at Camurus AB since 2015. He has been Director of the Company since 2010. He is Chairman of the Remuneration Committee and Member of the Audit Committee and Nomination Committee of the Company. He holds Master of Science in Pharmacy from Uppsala University. He has been in senior management at Merck Sharpe & Dohme, AstraZeneca, Pharmacia and Bristol-Myers Squibb and has served as CEO of Q-Med, Melacure and Karo Bio AB. He is currently Chairman of the Board of MB Erikssons Bygg & Fastighet AB, Arosgruppen Fastigheter Fjardingen AB, Arosgruppen Holding AB, Neo Dynamics AB and Patients Pending Ltd, Board member of Hansa Medical AB and Arosia Communication AB as well as Deputy Board member of Reabyran AB. He was previously Chairman of the Board of Aros Arkitekter AB and Chemilia AB as well as Board member of Mediplast AB and Aggal Invest AB.
|Total Annual Compensation,||--|
|Restricted Stock Awards,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|